EME - 15/48/20

A multicentre prospective randomised open-label blinded end-point controlled trial of cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent cardiac toxicity in anthracycline treated breast cancer patients

Project title: A multicentre prospective randomised open-label blinded end-point controlled trial of cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent cardiac toxicity in anthracycline treated breast cancer patients

Chief investigator: Dr Peter Henriksen

Contractor: The University of Edinburgh

Co-investigators: Dr John Payne, Dr Ninian Lang, Dr Olga Oikonomidou, Ms Abigail Marks, Ms Heather McVicars, Professor Chris Twelves, Professor David Newby, Professor Iain Macpherson, Professor Nicholas Mills, Professor Peter Hall, Professor Steff Lewis.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.